Recommendation

Unlock this content

CSL’s stock price has increased 29% over the past year and 105% since our initial Buy recommendation on 18 Mar 11 (Long Term Buy – $33.97), and is currently hovering around our Sell price of $70. That puts it on a seemingly expensive price-to-earnings ratio of 26, but as we're loath to let go of such a high quality company we want to analyse CSL’s interim results before considering...

Latest Q&A With Our Experts

Dear II As a newbie to your very informative website, I have noticed that the range between BUY and SELL recommendations for certain shares on your website is quite large. Two examples are shares I own: Ramsay Health Care (Buy <$45, Sell >$1...

InvestSMART Publishing Pty Ltd holds Australian Financial Securities Licence (AFSL) 282288.
The content of this website is general in nature and does not take the personal situation of any user of this website into consideration.
A user of this website should seek financial advice specific to that user’s situation before making any financial decision.
Past performance of any security or financial product is not a reliable indicator of future performance. InvestSMART Publishing Pty Ltd
encourages users of this website to view investing as a long-term pursuit.